AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE

AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE was reported 450 times

AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BEZOLD ABSCESS 1 0.1429
1 UREA URINE DECREASED 1 0.1000
2 PYLOROSPASM 1 0.0455
3 LISFRANC FRACTURE 1 0.0385
4 NONINFECTIVE CONJUNCTIVITIS 2 0.0200
5 ARTERIAL STENOSIS LIMB 1 0.0196
6 GASTROINTESTINAL MELANOSIS 1 0.0182
7 ELEPHANTIASIS 1 0.0149
8 ANAESTHETIC COMPLICATION CARDIAC 1 0.0145
9 ENTEROBIASIS 2 0.0134
10 ACTINIC ELASTOSIS 1 0.0132
11 BASE EXCESS INCREASED 1 0.0112
12 INJECTION SITE ECZEMA 2 0.0104
13 PINGUECULA 1 0.0094
14 PRODUCT CONTAMINATION CHEMICAL 2 0.0092
15 EXPOSURE TO MOULD 1 0.0079
16 APPLICATION SITE NODULE 1 0.0073
17 CHEMICAL BURNS OF EYE 2 0.0072
18 LUDWIG ANGINA 1 0.0069
19 ABSCESS SOFT TISSUE 1 0.0065
20 LENTIGO 3 0.0060
21 SOCIOECONOMIC PRECARITY 1 0.0058
22 PROCEDURAL HYPERTENSION 1 0.0053
23 DEAFNESS PERMANENT 1 0.0051
24 GLOMERULONEPHRITIS ACUTE 1 0.0049
25 HEAVY EXPOSURE TO ULTRAVIOLET LIGHT 1 0.0047
26 PERIPHERAL NERVE OPERATION 1 0.0046
27 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1 0.0043
28 VAGINAL MYCOSIS 1 0.0043
29 XEROSIS 5 0.0040
30 INFESTATION 1 0.0039
31 SOLAR DERMATITIS 1 0.0037
32 SPINAL CORD ABSCESS 1 0.0037
33 PERFUME SENSITIVITY 2 0.0035
34 PREMATURE AGEING 1 0.0034
35 PANCREATIC INJURY 1 0.0033
36 CAUSTIC INJURY 1 0.0032
37 OESOPHAGEAL ACHALASIA 2 0.0031
38 CONJUNCTIVITIS BACTERIAL 1 0.0029
39 SEBORRHOEIC KERATOSIS 4 0.0028
40 EAR OPERATION 1 0.0027
41 MESOTHELIOMA MALIGNANT 1 0.0027
42 ALBUMIN URINE PRESENT 1 0.0026
43 CHEMICAL BURN 3 0.0026
44 VERTEBRAL OSTEOPHYTE 1 0.0023
45 VULVOVAGINAL RASH 1 0.0023
46 PYOGENIC GRANULOMA 1 0.0021
47 DUST ALLERGY 2 0.0020
48 BLEPHARAL PIGMENTATION 1 0.0020
49 FAECAL VOLUME INCREASED 1 0.0019
50 SCAPULA FRACTURE 1 0.0019
51 RETROPERITONEAL LYMPHADENOPATHY 1 0.0019
52 HYPEREOSINOPHILIC SYNDROME 1 0.0018
53 INSTILLATION SITE REACTION 2 0.0018
54 PORTAL HYPERTENSIVE GASTROPATHY 1 0.0018
55 OPHTHALMIC HERPES SIMPLEX 1 0.0017
56 APPLICATION SITE DISCHARGE 2 0.0017
57 ANTERIOR CHAMBER INFLAMMATION 1 0.0017
58 RECTAL ADENOCARCINOMA 1 0.0017
59 SACRAL PAIN 1 0.0016
60 MITRAL VALVE CALCIFICATION 1 0.0016
61 HYPOTRICHOSIS 1 0.0016
62 HERPES OPHTHALMIC 2 0.0015
63 INJECTION SITE EXFOLIATION 1 0.0015
64 STASIS DERMATITIS 1 0.0015
65 PRODUCT EXPIRATION DATE ISSUE 2 0.0014
66 FUNGAL OESOPHAGITIS 1 0.0014
67 BORDERLINE PERSONALITY DISORDER 1 0.0014
68 BACTERIAL DISEASE CARRIER 1 0.0014
69 WITHDRAWAL BLEED 1 0.0014
70 SUNBURN 10 0.0013
71 DEBRIDEMENT 1 0.0013
72 ASPIRATION PLEURAL CAVITY 1 0.0013
73 ENDOCARDITIS BACTERIAL 1 0.0013
74 GUTTATE PSORIASIS 1 0.0012
75 OCULAR VASCULAR DISORDER 1 0.0012
76 ADRENAL MASS 1 0.0012
77 PERITONSILLAR ABSCESS 1 0.0012
78 BILIARY DYSKINESIA 2 0.0012
79 MILIARIA 2 0.0012
80 ABDOMINAL LYMPHADENOPATHY 1 0.0012
81 ENDOCRINE OPHTHALMOPATHY 1 0.0012
82 OESOPHAGEAL OBSTRUCTION 1 0.0012
83 FOLLICULAR LYMPHOMA 1 0.0011
84 ABDOMINAL SEPSIS 1 0.0011
85 MUSCLE CRAMP 2 0.0011
86 CATARRH 1 0.0011
87 INJECTION SITE DRYNESS 1 0.0011
88 LIGAMENT DISORDER 1 0.0011
89 C-REACTIVE PROTEIN 1 0.0011
90 LIPOATROPHY 1 0.0011
91 FACIAL ASYMMETRY 1 0.0010
92 SKIN TEXTURE ABNORMAL 1 0.0010
93 PCO2 DECREASED 1 0.0010
94 DUODENAL PERFORATION 1 0.0010
95 SKIN OEDEMA 1 0.0010
96 ONYCHALGIA 1 0.0010
97 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
98 IMMUNE-MEDIATED HEPATITIS 2 0.0010
99 RENAL MASS 2 0.0010
100 NASAL INFLAMMATION 1 0.0009
101 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
102 NAIL GROWTH ABNORMAL 1 0.0009
103 CARBON DIOXIDE DECREASED 1 0.0009
104 DILATATION ATRIAL 1 0.0009
105 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
106 APPLICATION SITE BURN 4 0.0008
107 MALIGNANT MELANOMA IN SITU 1 0.0008
108 INFREQUENT BOWEL MOVEMENTS 2 0.0008
109 JOINT WARMTH 1 0.0008
110 SKIN DEPIGMENTATION 1 0.0007
111 MENINGITIS VIRAL 1 0.0007
112 APPLICATION SITE EXFOLIATION 3 0.0007
113 FORCED EXPIRATORY VOLUME DECREASED 2 0.0007
114 AUDITORY DISORDER 1 0.0007
115 VASCULAR INJURY 1 0.0007
116 NONINFECTIVE GINGIVITIS 1 0.0007
117 FOOT AMPUTATION 1 0.0007
118 CONJUNCTIVITIS ALLERGIC 1 0.0007
119 ACNE CYSTIC 2 0.0007
120 REBOUND ACID HYPERSECRETION 2 0.0007
121 NEPHROGENIC ANAEMIA 3 0.0006
122 NEOPLASM SKIN 1 0.0006
123 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
124 HEPATITIS E 1 0.0006
125 TINEA PEDIS 1 0.0006
126 EXPOSURE TO TOXIC AGENT 2 0.0006
127 OROPHARYNGEAL BLISTERING 1 0.0006
128 SEBORRHOEIC DERMATITIS 1 0.0006
129 ARTHROPOD STING 1 0.0006
130 MALIGNANT MELANOMA 8 0.0006
131 EROSIVE OESOPHAGITIS 1 0.0006
132 BLOOD PH DECREASED 1 0.0006
133 SKIN HYPERPIGMENTATION 5 0.0006
134 CAROTID ARTERY STENOSIS 2 0.0006
135 DRUG SCREEN NEGATIVE 1 0.0006
136 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
137 PRODUCT TAMPERING 1 0.0006
138 CHEILITIS 3 0.0006
139 NASAL OEDEMA 1 0.0006
140 SOFT TISSUE INFECTION 1 0.0005
141 SENSITIVE SKIN 4 0.0005
142 BLOOD BICARBONATE DECREASED 1 0.0005
143 MOTION SICKNESS 1 0.0005
144 VOCAL CORD DISORDER 1 0.0005
145 APPLICATION SITE DISCOLOURATION 2 0.0005
146 DERMATITIS PSORIASIFORM 1 0.0005
147 PIGMENTATION DISORDER 3 0.0005
148 AORTIC DISSECTION 2 0.0005
149 PRE-EXISTING CONDITION IMPROVED 3 0.0005
150 PHYSICAL ASSAULT 1 0.0005
151 WALKING DISABILITY 1 0.0005
152 BODY HEIGHT DECREASED 5 0.0005
153 APPLICATION SITE SCAB 1 0.0005
154 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
155 MELANOCYTIC NAEVUS 2 0.0005
156 LIMB MASS 1 0.0005
157 DANDRUFF 1 0.0005
158 GASTROINTESTINAL ULCER 1 0.0005
159 SKIN MASS 3 0.0004
160 APPLICATION SITE URTICARIA 1 0.0004
161 METASTATIC MALIGNANT MELANOMA 1 0.0004
162 CYTOMEGALOVIRUS COLITIS 1 0.0004
163 HAEMANGIOMA 1 0.0004
164 BREAKTHROUGH PAIN 1 0.0004
165 VITILIGO 1 0.0004
166 PUSTULE 1 0.0004
167 APPLICATION SITE ERYTHEMA 11 0.0004
168 EYE OEDEMA 1 0.0004
169 INSTILLATION SITE PAIN 1 0.0004
170 APPLICATION SITE SWELLING 2 0.0004
171 PROTEIN URINE PRESENT 2 0.0004
172 HYPERPARATHYROIDISM SECONDARY 1 0.0004
173 VENTRICULAR HYPERTROPHY 1 0.0004
174 RETINAL ARTERY OCCLUSION 1 0.0004
175 LABYRINTHITIS 1 0.0004
176 CHEMICAL BURN OF SKIN 1 0.0004
177 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
178 ACTINIC KERATOSIS 1 0.0004
179 DERMATITIS 8 0.0004
180 SENSITIVITY TO WEATHER CHANGE 2 0.0004
181 NASAL DISORDER 1 0.0004
182 BLOOD POTASSIUM ABNORMAL 1 0.0004
183 SKIN DISCOMFORT 1 0.0004
184 SKIN WRINKLING 1 0.0004
185 APPLICATION SITE HAEMORRHAGE 1 0.0004
186 PHOTOSENSITIVITY REACTION 6 0.0004
187 RED BLOOD CELL COUNT INCREASED 1 0.0004
188 HYPERKERATOSIS 2 0.0004
189 VITREOUS HAEMORRHAGE 1 0.0004
190 TRICHORRHEXIS 1 0.0004
191 CHOLECYSTITIS ACUTE 2 0.0004
192 JOINT LOCK 1 0.0004
193 IMPAIRED DRIVING ABILITY 4 0.0004
194 PHARYNGEAL DISORDER 1 0.0003
195 SKIN WARM 2 0.0003
196 DYSCHEZIA 1 0.0003
197 MEDICAL DEVICE DISCOMFORT 1 0.0003
198 MASTICATION DISORDER 1 0.0003
199 DIABETIC FOOT 1 0.0003
200 EYELIDS PRURITUS 1 0.0003
201 APPLICATION SITE PAIN 7 0.0003
202 FOREIGN BODY IN THROAT 1 0.0003
203 CARDIAC FLUTTER 2 0.0003
204 APPLICATION SITE VESICLES 2 0.0003
205 DEAFNESS NEUROSENSORY 1 0.0003
206 SKIN INJURY 1 0.0003
207 TONGUE ULCERATION 1 0.0003
208 WOUND DEHISCENCE 1 0.0003
209 ULCER HAEMORRHAGE 2 0.0003
210 ABNORMAL LOSS OF WEIGHT 2 0.0003
211 HANGOVER 1 0.0003
212 THERMAL BURN 2 0.0003
213 SKIN WEEPING 1 0.0003
214 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
215 SCLERODERMA 1 0.0003
216 INTENTIONAL UNDERDOSE 2 0.0003
217 FREEZING PHENOMENON 1 0.0003
218 SKIN HAEMORRHAGE 4 0.0003
219 DERMATITIS CONTACT 3 0.0003
220 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
221 OESOPHAGEAL ULCER 1 0.0003
222 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
223 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
224 BASAL CELL CARCINOMA 4 0.0003
225 ORAL INFECTION 1 0.0003
226 WOUND SECRETION 1 0.0003
227 PROSTATOMEGALY 1 0.0003
228 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
229 HYPERPHAGIA 1 0.0003
230 AZOTAEMIA 1 0.0003
231 SKIN PAPILLOMA 1 0.0002
232 MIOSIS 2 0.0002
233 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
234 TRIGGER FINGER 1 0.0002
235 SPINAL COMPRESSION FRACTURE 2 0.0002
236 SOCIAL PROBLEM 1 0.0002
237 THYROID FUNCTION TEST ABNORMAL 1 0.0002
238 SELF-INJURIOUS IDEATION 1 0.0002
239 SLEEP TERROR 1 0.0002
240 SKIN PLAQUE 2 0.0002
241 TONGUE DISCOMFORT 1 0.0002
242 PURULENT DISCHARGE 1 0.0002
243 HORDEOLUM 1 0.0002
244 OCULAR ICTERUS 1 0.0002
245 CHAPPED LIPS 1 0.0002
246 NAIL DISORDER 2 0.0002
247 ONYCHOMYCOSIS 1 0.0002
248 APPLICATION SITE PRURITUS 5 0.0002
249 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
250 EXOSTOSIS 2 0.0002
251 SKIN LESION 6 0.0002
252 APPLICATION SITE RASH 3 0.0002
253 ARTHRITIS INFECTIVE 1 0.0002
254 GASTRITIS EROSIVE 1 0.0002
255 SKIN TIGHTNESS 1 0.0002
256 SQUAMOUS CELL CARCINOMA 2 0.0002
257 BLOOD PROLACTIN INCREASED 1 0.0002
258 SKIN ABRASION 1 0.0002
259 SPINAL DISORDER 2 0.0002
260 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
261 ENDOMETRIOSIS 1 0.0002
262 SUBCUTANEOUS ABSCESS 1 0.0002
263 VULVOVAGINAL PAIN 1 0.0002
264 INCORRECT DOSAGE ADMINISTERED 1 0.0002
265 PHARYNGEAL SWELLING 2 0.0002
266 ORGANISING PNEUMONIA 1 0.0002
267 HEPATIC ENZYME ABNORMAL 1 0.0002
268 VEIN DISORDER 1 0.0002
269 CORONARY ARTERY STENOSIS 1 0.0002
270 VULVOVAGINAL PRURITUS 1 0.0002
271 DYSLIPIDAEMIA 1 0.0002
272 AMMONIA INCREASED 1 0.0002
273 SKIN NECROSIS 1 0.0002
274 EYE DISCHARGE 2 0.0002
275 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
276 ANAL FISTULA 1 0.0002
277 OVERWEIGHT 1 0.0002
278 POOR QUALITY SLEEP 4 0.0002
279 PHARYNGITIS STREPTOCOCCAL 2 0.0002
280 ERYTHEMA OF EYELID 1 0.0002
281 BIPOLAR DISORDER 2 0.0002
282 ASTHENOPIA 1 0.0002
283 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
284 STREPTOCOCCAL INFECTION 1 0.0002
285 NECROSIS 1 0.0002
286 INTRACRANIAL PRESSURE INCREASED 1 0.0002
287 GLOSSODYNIA 4 0.0002
288 ANGIOPATHY 1 0.0002
289 ACUTE PULMONARY OEDEMA 1 0.0002
290 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
291 EYE INFECTION 2 0.0002
292 GENERALISED ERYTHEMA 1 0.0002
293 CHOLECYSTECTOMY 2 0.0002
294 SKIN ATROPHY 1 0.0002
295 HYPERVENTILATION 1 0.0002
296 METABOLIC DISORDER 1 0.0002
297 RALES 1 0.0002
298 VASCULITIS 2 0.0002
299 PRODUCT LABEL CONFUSION 1 0.0002
300 HYPERTRIGLYCERIDAEMIA 1 0.0002
301 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
302 CATARACT OPERATION 1 0.0002
303 SINUS HEADACHE 1 0.0002
304 PROTHROMBIN TIME PROLONGED 1 0.0002
305 WRIST FRACTURE 2 0.0002
306 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
307 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
308 INJECTION SITE VESICLES 1 0.0002
309 SCOLIOSIS 1 0.0002
310 BLISTER 9 0.0002
311 CHRONIC KIDNEY DISEASE 12 0.0002
312 FOREIGN BODY SENSATION IN EYES 1 0.0002
313 EYE IRRITATION 9 0.0002
314 POOR QUALITY DRUG ADMINISTERED 1 0.0002
315 ORAL HERPES 3 0.0002
316 SWELLING FACE 10 0.0002
317 TENDON DISORDER 1 0.0002
318 POLYP 1 0.0002
319 IMMUNE SYSTEM DISORDER 2 0.0002
320 WALKING AID USER 1 0.0002
321 PRODUCT FORMULATION ISSUE 1 0.0002
322 SARS-COV-2 TEST POSITIVE 2 0.0002
323 CHOLECYSTITIS CHRONIC 1 0.0001
324 PAIN OF SKIN 4 0.0001
325 PRODUCT LABEL ISSUE 1 0.0001
326 IMPAIRED GASTRIC EMPTYING 2 0.0001
327 MOOD ALTERED 4 0.0001
328 BLOOD TESTOSTERONE DECREASED 1 0.0001
329 INFARCTION 1 0.0001
330 DROOLING 1 0.0001
331 ENCEPHALITIS 1 0.0001
332 HAIR GROWTH ABNORMAL 1 0.0001
333 HUNGER 2 0.0001
334 EXTRASYSTOLES 1 0.0001
335 DEFAECATION URGENCY 1 0.0001
336 APPLICATION SITE REACTION 1 0.0001
337 SEASONAL ALLERGY 2 0.0001
338 RETINAL HAEMORRHAGE 1 0.0001
339 IMPAIRED WORK ABILITY 3 0.0001
340 PRODUCT SUPPLY ISSUE 1 0.0001
341 RASH PUSTULAR 1 0.0001
342 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
343 ECZEMA 7 0.0001
344 SNEEZING 3 0.0001
345 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
346 RESPIRATORY DISORDER 4 0.0001
347 ACNE 10 0.0001
348 PRODUCT AVAILABILITY ISSUE 3 0.0001
349 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
350 BLOOD CHOLESTEROL INCREASED 6 0.0001
351 ACUTE MYELOID LEUKAEMIA 2 0.0001
352 PULMONARY HAEMORRHAGE 1 0.0001
353 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
354 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
355 MUSCLE DISORDER 1 0.0001
356 BLOOD POTASSIUM INCREASED 2 0.0001
357 HYPERAESTHESIA 1 0.0001
358 HAIR DISORDER 1 0.0001
359 EXPIRED PRODUCT ADMINISTERED 4 0.0001
360 EYE PRURITUS 4 0.0001
361 SCAR 2 0.0001
362 PARANOIA 2 0.0001
363 CARDIAC MURMUR 1 0.0001
364 SKIN SWELLING 1 0.0001
365 BLOOD CALCIUM INCREASED 1 0.0001
366 IMMUNOSUPPRESSION 1 0.0001
367 RESPIRATORY RATE INCREASED 1 0.0001
368 FACIAL PAIN 1 0.0001
369 JAUNDICE 3 0.0001
370 OSTEOMYELITIS 2 0.0001
371 LIP DRY 1 0.0001
372 END STAGE RENAL DISEASE 2 0.0001
373 SKIN IRRITATION 5 0.0001
374 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
375 PNEUMONIA BACTERIAL 1 0.0001
376 CONJUNCTIVITIS 2 0.0001
377 MIDDLE INSOMNIA 2 0.0001
378 DIARRHOEA HAEMORRHAGIC 1 0.0001
379 FLANK PAIN 1 0.0001
380 HEPATIC CIRRHOSIS 2 0.0001
381 PRODUCT USE ISSUE 20 0.0001
382 PHOTOPHOBIA 2 0.0001
383 ARTERIOSCLEROSIS 1 0.0001
384 DRY SKIN 14 0.0001
385 RASH ERYTHEMATOUS 5 0.0001
386 PULMONARY FIBROSIS 2 0.0001
387 CHOLESTASIS 2 0.0001
388 ACUTE RESPIRATORY FAILURE 2 0.0001
389 DIZZINESS POSTURAL 1 0.0001
390 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
391 SKIN FISSURES 2 0.0001
392 URINARY INCONTINENCE 3 0.0001
393 LIGAMENT SPRAIN 1 0.0001
394 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
395 DRY EYE 5 0.0001
396 SPINAL FRACTURE 2 0.0001
397 THERAPY CESSATION 5 0.0001
398 TEMPERATURE INTOLERANCE 1 0.0001
399 SKELETAL INJURY 1 0.0001
400 HYPERBILIRUBINAEMIA 1 0.0001
401 PETECHIAE 1 0.0001
402 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
403 SKIN EXFOLIATION 8 0.0001
404 SCRATCH 1 0.0001
405 SKIN CANCER 2 0.0001
406 DECREASED ACTIVITY 1 0.0001
407 ERYTHEMA 19 0.0001
408 INTENTIONAL PRODUCT MISUSE 8 0.0001
409 ASPIRATION 1 0.0001
410 BLOOD GLUCOSE FLUCTUATION 1 0.0001
411 GASTROINTESTINAL PAIN 1 0.0001
412 FOOT DEFORMITY 1 0.0001
413 SKIN DISORDER 3 0.0001
414 NERVE INJURY 1 0.0001
415 RASH PAPULAR 2 0.0001
416 HEART RATE IRREGULAR 2 0.0001
417 MITRAL VALVE INCOMPETENCE 1 0.0001
418 SCAB 1 0.0001
419 SKIN DISCOLOURATION 4 0.0001
420 NEOPLASM 1 0.0001
421 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
422 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
423 PERICARDIAL EFFUSION 2 0.0001
424 MADAROSIS 1 0.0001
425 EYELID OEDEMA 1 0.0001
426 BURNING SENSATION 6 0.0001
427 SPINAL PAIN 1 0.0001
428 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
429 SKIN BURNING SENSATION 6 0.0001
430 DRUG EFFECT INCOMPLETE 3 0.0001
431 MENTAL IMPAIRMENT 2 0.0001
432 BURSITIS 1 0.0001
433 SCHIZOPHRENIA 1 0.0001
434 DYSURIA 3 0.0001
435 CARDIOMEGALY 1 0.0001
436 INJECTION SITE EXTRAVASATION 1 0.0001
437 HEART RATE INCREASED 8 0.0001
438 EYE SWELLING 3 0.0001
439 CYST 1 0.0001
440 ILEUS 1 0.0001
441 APPLICATION SITE IRRITATION 1 0.0001
442 HAIR COLOUR CHANGES 1 0.0001
443 SECRETION DISCHARGE 1 0.0001
444 DYSPNOEA EXERTIONAL 3 0.0001
445 INTESTINAL OBSTRUCTION 3 0.0001
446 INJECTION SITE IRRITATION 1 0.0001
447 ACUTE KIDNEY INJURY 12 0.0001
448 INFLAMMATION 4 0.0001
449 HIATUS HERNIA 1 0.0001
450 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
451 NODULE 1 0.0001
452 INCORRECT PRODUCT STORAGE 1 0.0001
453 ORAL CANDIDIASIS 1 0.0001
454 RENAL FAILURE 10 0.0001
455 FEAR 2 0.0001
456 TACHYPNOEA 1 0.0001
457 ORAL DISCOMFORT 1 0.0001
458 HAEMOPTYSIS 2 0.0001
459 SKIN REACTION 1 0.0001
460 BLINDNESS UNILATERAL 1 0.0001
461 EYE PAIN 4 0.0001
462 FLATULENCE 4 0.0001
463 DIALYSIS 1 0.0001
464 BRONCHOSPASM 1 0.0001
465 HYPERSENSITIVITY 13 0.0001
466 RECTAL HAEMORRHAGE 3 0.0001
467 IMPAIRED QUALITY OF LIFE 1 0.0001
468 PARAESTHESIA ORAL 1 0.0001
469 MYELODYSPLASTIC SYNDROME 1 0.0001
470 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
471 SEPTIC SHOCK 3 0.0001
472 MUSCULOSKELETAL STIFFNESS 6 0.0001
473 ASCITES 2 0.0001
474 THROAT IRRITATION 3 0.0001
475 HYPOAESTHESIA ORAL 1 0.0001
476 LACRIMATION INCREASED 2 0.0001
477 CORONARY ARTERY DISEASE 2 0.0001
478 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
479 DEVICE FAILURE 1 0.0001
480 HIP ARTHROPLASTY 1 0.0001
481 MUSCULOSKELETAL CHEST PAIN 1 0.0001
482 DELUSION 1 0.0001
483 EJECTION FRACTION DECREASED 1 0.0001
484 SWELLING 6 0.0001
485 OCULAR HYPERAEMIA 3 0.0001
486 DISEASE RECURRENCE 3 0.0001
487 CYSTITIS 2 0.0001
488 MOVEMENT DISORDER 2 0.0001
489 RASH 27 0.0001
490 DRY MOUTH 5 0.0001
491 DEPRESSION 14 0.0001
492 BACK DISORDER 1 0.0001
493 PSORIASIS 8 0.0001
494 IMPAIRED HEALING 2 0.0001
495 MANIA 1 0.0001
496 STAPHYLOCOCCAL INFECTION 2 0.0001
497 PRURITUS 23 0.0001
498 BLOOD UREA INCREASED 1 0.0001
499 URTICARIA 10 0.0001
500 TYPE 2 DIABETES MELLITUS 2 0.0001
501 HEMIPARESIS 1 0.0001
502 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
503 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
504 MUSCULOSKELETAL DISCOMFORT 1 0.0001
505 MULTI-ORGAN FAILURE 1 0.0001
506 DEVICE DEFECTIVE 1 0.0001
507 RASH MACULAR 2 0.0001
508 HEART RATE DECREASED 2 0.0001
509 INJURY 4 0.0001
510 SLEEP DISORDER 4 0.0001
511 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
512 GALLBLADDER DISORDER 1 0.0001
513 THIRST 1 0.0001
514 GOUT 1 0.0001
515 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
516 GASTROENTERITIS VIRAL 1 0.0001
517 TOOTHACHE 1 0.0001
518 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
519 CONSTIPATION 12 0.0001
520 UNDERDOSE 4 0.0001
521 SUICIDAL IDEATION 5 0.0001
522 INJECTION SITE MASS 2 0.0001
523 BACTERIAL INFECTION 1 0.0001
524 HYPOCALCAEMIA 1 0.0001
525 COLITIS 2 0.0001
526 ANXIETY 15 0.0001
527 BLOOD URINE PRESENT 1 0.0001
528 GASTRIC ULCER 1 0.0001
529 SLEEP APNOEA SYNDROME 1 0.0001
530 INCREASED APPETITE 1 0.0001
531 BLOOD PRESSURE INCREASED 8 0.0001
532 POST PROCEDURAL COMPLICATION 1 0.0001
533 DRUG PRESCRIBING ERROR 1 0.0001
534 HYPERTENSION 11 0.0001
535 ERUCTATION 1 0.0001
536 DISABILITY 1 0.0001
537 SINUS DISORDER 1 0.0001
538 HAEMATOCRIT DECREASED 1 0.0001
539 SOMNOLENCE 10 0.0000
540 PRODUCT ADMINISTRATION ERROR 1 0.0000
541 FEEDING DISORDER 1 0.0000
542 PSORIATIC ARTHROPATHY 2 0.0000
543 DISCOMFORT 3 0.0000
544 INJURY ASSOCIATED WITH DEVICE 1 0.0000
545 BLINDNESS 2 0.0000
546 LUNG NEOPLASM MALIGNANT 2 0.0000
547 OSTEOPOROSIS 2 0.0000
548 RIB FRACTURE 1 0.0000
549 ILLNESS 5 0.0000
550 PULMONARY HYPERTENSION 1 0.0000
551 POLLAKIURIA 2 0.0000
552 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
553 ABDOMINAL DISCOMFORT 8 0.0000
554 MOUTH ULCERATION 1 0.0000
555 HALLUCINATION, VISUAL 1 0.0000
556 RENAL FAILURE ACUTE 2 0.0000
557 JOINT INJURY 1 0.0000
558 IRRITABLE BOWEL SYNDROME 1 0.0000
559 LIVER FUNCTION TEST INCREASED 1 0.0000
560 COUGH 13 0.0000
561 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
562 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
563 LIVER DISORDER 2 0.0000
564 STEVENS-JOHNSON SYNDROME 1 0.0000
565 RASH MACULO-PAPULAR 1 0.0000
566 WEIGHT INCREASED 10 0.0000
567 PRODUCT QUALITY ISSUE 6 0.0000
568 PAIN IN EXTREMITY 13 0.0000
569 MUSCULAR WEAKNESS 5 0.0000
570 ABDOMINAL PAIN UPPER 9 0.0000
571 TINNITUS 2 0.0000
572 MUSCLE TWITCHING 1 0.0000
573 ARTHRALGIA 18 0.0000
574 COGNITIVE DISORDER 2 0.0000
575 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
576 DYSPHAGIA 4 0.0000
577 PRODUCTIVE COUGH 2 0.0000
578 BLOOD PRESSURE FLUCTUATION 1 0.0000
579 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
580 DIABETIC KETOACIDOSIS 1 0.0000
581 CONTUSION 4 0.0000
582 LOCALISED INFECTION 1 0.0000
583 ATRIAL FIBRILLATION 4 0.0000
584 ENCEPHALOPATHY 1 0.0000
585 DYSPEPSIA 4 0.0000
586 DYSPNOEA 23 0.0000
587 ABASIA 1 0.0000
588 DYSGEUSIA 3 0.0000
589 PNEUMONIA ASPIRATION 1 0.0000
590 CELLULITIS 2 0.0000
591 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
592 ABDOMINAL PAIN LOWER 1 0.0000
593 GASTRIC CANCER 1 0.0000
594 PRODUCT COMPLAINT 1 0.0000
595 HAEMATEMESIS 1 0.0000
596 WEIGHT DECREASED 11 0.0000
597 DIABETES MELLITUS 3 0.0000
598 INJECTION SITE SWELLING 3 0.0000
599 HYPOPHAGIA 1 0.0000
600 HEPATITIS 1 0.0000
601 CHEST DISCOMFORT 4 0.0000
602 SKIN ULCER 1 0.0000
603 HAEMATOMA 1 0.0000
604 ABDOMINAL DISTENSION 4 0.0000
605 MUSCULOSKELETAL PAIN 2 0.0000
606 MUSCLE SPASMS 7 0.0000
607 JOINT STIFFNESS 1 0.0000
608 GASTRITIS 1 0.0000
609 EAR INFECTION 1 0.0000
610 BREAST CANCER FEMALE 1 0.0000
611 MENSTRUATION IRREGULAR 1 0.0000
612 FREQUENT BOWEL MOVEMENTS 1 0.0000
613 THROAT TIGHTNESS 1 0.0000
614 RASH PRURITIC 2 0.0000
615 OEDEMA 2 0.0000
616 LIMB INJURY 1 0.0000
617 PALLOR 1 0.0000
618 HEADACHE 23 0.0000
619 INFLUENZA LIKE ILLNESS 3 0.0000
620 VISION BLURRED 5 0.0000
621 DRUG DOSE OMISSION 6 0.0000
622 RESPIRATORY DISTRESS 1 0.0000
623 ABNORMAL DREAMS 1 0.0000
624 FALL 12 0.0000
625 PROCEDURAL PAIN 1 0.0000
626 NECK PAIN 2 0.0000
627 WOUND 1 0.0000
628 RENAL IMPAIRMENT 3 0.0000
629 ALOPECIA 7 0.0000
630 URINARY TRACT INFECTION 6 0.0000
631 INTENTIONAL DOSE OMISSION 1 0.0000
632 RED BLOOD CELL COUNT DECREASED 1 0.0000
633 HYPERSOMNIA 1 0.0000
634 LETHARGY 2 0.0000
635 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
636 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
637 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
638 BACK PAIN 8 0.0000
639 DYSSTASIA 1 0.0000
640 COVID-19 6 0.0000
641 PAIN 21 0.0000
642 PALPITATIONS 4 0.0000
643 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
644 NASAL CONGESTION 2 0.0000
645 PSYCHOTIC DISORDER 1 0.0000
646 TACHYCARDIA 3 0.0000
647 CATARACT 2 0.0000
648 IRRITABILITY 2 0.0000
649 JOINT SWELLING 4 0.0000
650 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
651 STOMATITIS 2 0.0000
652 CONDITION AGGRAVATED 10 0.0000
653 PLEURAL EFFUSION 2 0.0000
654 OEDEMA PERIPHERAL 4 0.0000
655 FEELING HOT 2 0.0000
656 ADVERSE EVENT 3 0.0000
657 EMOTIONAL DISORDER 1 0.0000
658 OROPHARYNGEAL PAIN 3 0.0000
659 CHEST PAIN 6 0.0000
660 GYNAECOMASTIA 1 0.0000
661 CARDIAC DISORDER 3 0.0000
662 NERVOUS SYSTEM DISORDER 1 0.0000
663 HEAD INJURY 1 0.0000
664 PULMONARY EMBOLISM 3 0.0000
665 HYPOTHYROIDISM 1 0.0000
666 HIP FRACTURE 1 0.0000
667 FATIGUE 24 0.0000
668 OSTEONECROSIS 1 0.0000
669 EYE DISORDER 1 0.0000
670 VISUAL ACUITY REDUCED 1 0.0000
671 BLOOD PRESSURE DECREASED 2 0.0000
672 INSOMNIA 8 0.0000
673 LIP SWELLING 1 0.0000
674 FUNGAL INFECTION 1 0.0000
675 DEHYDRATION 4 0.0000
676 URINARY RETENTION 1 0.0000
677 GAIT INABILITY 1 0.0000
678 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
679 HEPATIC ENZYME INCREASED 2 0.0000
680 HAEMATURIA 1 0.0000
681 GASTRIC DISORDER 1 0.0000
682 HYPERKALAEMIA 1 0.0000
683 DIZZINESS 14 0.0000
684 OVERDOSE 6 0.0000
685 MYELOSUPPRESSION 1 0.0000
686 INFECTION 4 0.0000
687 CRYING 1 0.0000
688 C-REACTIVE PROTEIN INCREASED 1 0.0000
689 HYPERGLYCAEMIA 1 0.0000
690 RESTLESSNESS 1 0.0000
691 NASOPHARYNGITIS 5 0.0000
692 BRONCHITIS 2 0.0000
693 HEPATIC FUNCTION ABNORMAL 1 0.0000
694 HYPOAESTHESIA 4 0.0000
695 ASTHMA 3 0.0000
696 HOT FLUSH 2 0.0000
697 BLOOD GLUCOSE INCREASED 5 0.0000
698 UNEVALUABLE EVENT 2 0.0000
699 GAIT DISTURBANCE 5 0.0000
700 HOSPITALISATION 4 0.0000
701 SEIZURE 3 0.0000
702 PERIPHERAL SWELLING 4 0.0000
703 ABDOMINAL PAIN 6 0.0000
704 PLASMA CELL MYELOMA 1 0.0000
705 ARTHRITIS 2 0.0000
706 ABNORMAL BEHAVIOUR 1 0.0000
707 DISORIENTATION 1 0.0000
708 INJECTION SITE HAEMORRHAGE 2 0.0000
709 CARDIAC FAILURE 2 0.0000
710 CARDIAC FAILURE CONGESTIVE 2 0.0000
711 DIARRHOEA 16 0.0000
712 EMOTIONAL DISTRESS 3 0.0000
713 PNEUMONIA 8 0.0000
714 EXTRA DOSE ADMINISTERED 1 0.0000
715 NEUTROPHIL COUNT DECREASED 1 0.0000
716 INJECTION SITE ERYTHEMA 3 0.0000
717 TREMOR 4 0.0000
718 ASTHENIA 9 0.0000
719 CARDIO-RESPIRATORY ARREST 1 0.0000
720 ROAD TRAFFIC ACCIDENT 1 0.0000
721 CEREBROVASCULAR ACCIDENT 4 0.0000
722 OSTEOARTHRITIS 1 0.0000
723 MYALGIA 4 0.0000
724 LOSS OF CONSCIOUSNESS 3 0.0000
725 HYPERHIDROSIS 3 0.0000
726 MENTAL DISORDER 1 0.0000
727 PRODUCT STORAGE ERROR 2 0.0000
728 ANGIOEDEMA 1 0.0000
729 ADVERSE DRUG REACTION 2 0.0000
730 INCORRECT DOSE ADMINISTERED 5 0.0000
731 NEPHROLITHIASIS 1 0.0000
732 HYPOKALAEMIA 1 0.0000
733 DECREASED APPETITE 5 0.0000
734 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
735 VOMITING 10 0.0000
736 ARRHYTHMIA 1 0.0000
737 MIGRAINE 2 0.0000
738 MULTIPLE SCLEROSIS 1 0.0000
739 DRUG INTOLERANCE 2 0.0000
740 MALAISE 9 0.0000
741 DRUG INEFFECTIVE 27 0.0000
742 PRODUCT DOSE OMISSION ISSUE 6 0.0000
743 NAUSEA 16 0.0000
744 SYNCOPE 2 0.0000
745 HYPOTENSION 4 0.0000
746 FLUID RETENTION 1 0.0000
747 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
748 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
749 NERVOUSNESS 1 0.0000
750 HAEMORRHAGE 2 0.0000
751 DERMATITIS ATOPIC 1 0.0000
752 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
753 OFF LABEL USE 16 0.0000
754 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
755 ANAPHYLACTIC REACTION 1 0.0000
756 ARTHROPATHY 1 0.0000
757 INFLUENZA 2 0.0000
758 SEPSIS 2 0.0000
759 PANCYTOPENIA 1 0.0000
760 OXYGEN SATURATION DECREASED 1 0.0000
761 HYPONATRAEMIA 1 0.0000
762 CONVULSION 1 0.0000
763 HERPES ZOSTER 1 0.0000
764 PRODUCT SUBSTITUTION ISSUE 1 0.0000
765 PYREXIA 6 0.0000
766 MYOCARDIAL INFARCTION 3 0.0000
767 DYSPHONIA 1 0.0000
768 BONE PAIN 1 0.0000
769 DISEASE PROGRESSION 2 0.0000
770 THERAPEUTIC RESPONSE DECREASED 1 0.0000
771 INJECTION SITE PAIN 5 0.0000
772 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
773 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
774 VISUAL IMPAIRMENT 2 0.0000
775 DEEP VEIN THROMBOSIS 1 0.0000
776 PRODUCT DOSE OMISSION 1 0.0000
777 BLOOD CREATININE INCREASED 1 0.0000
778 NEOPLASM MALIGNANT 1 0.0000
779 INJECTION SITE PRURITUS 1 0.0000
780 NEUTROPENIA 2 0.0000
781 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
782 INJECTION SITE REACTION 1 0.0000
783 MOBILITY DECREASED 1 0.0000
784 RESPIRATORY FAILURE 1 0.0000
785 EPISTAXIS 1 0.0000
786 HALLUCINATION 1 0.0000
787 PARAESTHESIA 2 0.0000
788 INJECTION SITE BRUISING 1 0.0000
789 FEELING ABNORMAL 3 0.0000
790 DRUG DEPENDENCE 2 0.0000
791 CONFUSIONAL STATE 2 0.0000
792 BALANCE DISORDER 1 0.0000
793 GASTROINTESTINAL DISORDER 1 0.0000
794 DEVICE ISSUE 1 0.0000
795 ANAEMIA 2 0.0000
796 FLUSHING 1 0.0000
797 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
798 SINUSITIS 1 0.0000
799 HAEMOGLOBIN DECREASED 1 0.0000
800 PLATELET COUNT DECREASED 1 0.0000
801 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
802 RHEUMATOID ARTHRITIS 1 0.0000
803 CHILLS 1 0.0000
804 DRUG INTERACTION 1 0.0000
805 DEATH 5 0.0000
806 NO ADVERSE EVENT 1 0.0000